The effect of COVID-19 pandemic on chronic disease treatment and health condition among Chinese adults
-
摘要:
目的 探讨COVID-19疫情对中国成人慢性病治疗及健康状况的影响。 方法 通过随机数字拨号方法在全国所有地市级行政单位抽取≥18岁的人群样本,通过云端电话调查系统开展问卷访问,于2020年11―12月共收集具有全国代表性的问卷5 972份。 结果 高血压患者、血脂异常患者、糖尿病/血糖升高患者中分别有2.2%、4.6%和8.8%的患者其治疗受COVID-19疫情的影响比较大或非常大。与疫情前相比,有4.2%的人群报告健康状况明显变差或有所变差。高血压患者中,自报健康状况越差,其治疗受COVID-19疫情的影响越大;血脂异常患者中,年龄越大、家庭收入低、自报健康状况越差,其血脂异常的治疗受COVID-19疫情的影响越大;中老年人、居住在城市的人群健康变差的可能性大。 结论 目前,中国高血压、血脂异常、糖尿病/血糖升高患者的治疗以及人群健康状况受疫情的影响不大,对于受影响较大的高危人群需要特别给予关注。 Abstract:Objective To explore the effect of COVID-19 pandemic on chronic disease treatment and health condition among Chinese adults. Methods Random digital dialing method was used to extract respondents aged 18 years old and over from all prefectural level areas in China. A cloud-based telephone interviewing system was administered to do the questionnaire survey. A total number of 5 972 questionnaires were collected nationally from November to December 2020. Results The COVID-19 pandemic had some or high degree impact on hypertension treatment of 2.2% self-reported patients. In addition, 4.6% and 8.8% of patients with dyslipidemia and diabetes or high glucose were affected by COVID-19. Compared with prepandemic, a total number of 4.2% population reported a little bit or significantly worse health condition. Results showed that the treatment of hypertension was affected more by COVID-19 pandemic among patients with worse health condition. The treatment of dyslipidemia was affected more by COVID-19 pandemic among old age and low family income patients with worse health condition. Middle and old age, urban people had higher chance to getting worse heath during COVID-19 pandemic. Conclusions The COVID-19 pandemic has little impact on treatment of hypertension, dyslipidemia, diabetes or high glucose patients and overall health status among Chinese population at present. But special attention should paid to high risk population with chronic disease who disproportionately affected by pandemic. -
Key words:
- COVID-19 /
- Hypertension /
- Dyslipidemia /
- High glucose /
- Health status
-
表 1 不同慢性病患病、健康状况及受疫情影响情况
Table 1. Different chronic disease prevalence, health status and affected state by pandemic
变量 例数 百分比(%) 高血压 有 647 10.8 无 5 324 89.2 COVID-19疫情对高血压治疗的影响 影响非常大 4 0.6 影响比较大 10 1.6 影响一般 59 9.2 影响比较小 40 6.2 基本没有影响 531 82.4 血脂异常 有 679 11.4 无 5 286 88.6 COVID-19疫情对血脂异常治疗的影响 影响非常大 7 1.0 影响比较大 24 3.6 影响一般 73 10.8 影响比较小 45 6.6 基本没有影响 528 78.0 糖尿病/血糖升高 有 299 5.0 无 5 672 95.0 COVID-19疫情对糖尿病/血糖治疗的影响 影响非常大 8 2.7 影响比较大 18 6.1 影响一般 41 13.8 影响比较小 16 5.4 基本没有影响 214 72.0 自报身体健康状况 很不健康 41 0.7 比较不健康 161 2.7 一般 1 342 22.5 比较健康 2 341 39.2 很健康 2 085 34.9 身体健康受到此次COVID-19疫情的影响 明显变差 24 0.4 有所变差 228 3.8 基本没变化 5 340 89.4 有所变好 263 4.4 明显变好 116 1.9 表 2 不同特征人群慢性病患病及总体健康状况受COVID-19疫情的影响情况[n (%)]
Table 2. Chronic disease prevalence and overall health status affected by COVID-19 pandemic among different population [n (%)]
变量 对高血压的治疗有影响 对血脂异常的治疗有影响 对糖尿病/血糖升高的治疗有影响 身体健康变差 例数(N) n(%) χ2值 P值 例数(N) n(%) χ2值 P值 例数(N) n(%) χ2值 P值 例数(N) n(%) χ2值 P值 性别 0.001 0.976 2.532 0.112 0.954 0.329 1.344 0.246 男性 478 84(17.6) 472 96(20.3) 216 57(26.4) 3 534 158(4.5) 女性 166 29(17.5) 205 53(25.8) 81 26(32.1) 2 437 94(3.9) 年龄(岁) 1.380 0.502 10.509 0.005 4.571 0.102 14.851 0.001 18~<45 189 28(14.8) 270 43(15.9) 102 25(24.5) 4 367 158(3.6) 45~<60 257 48(18.7) 256 63(24.6) 114 28(24.6) 1 111 67(6.0) ≥60 198 37(18.7) 151 43(28.5) 81 30(37.0) 493 24(5.5) 居住地区 0.038 0.846 0.758 0.384 0.097 0.755 12.921 < 0.001 城市 474 82(17.3) 564 120(21.3) 231 63(27.3) 4 679 221(4.7) 农村 167 30(18.0) 112 28(25.0) 65 19(29.2) 1 273 31(2.4) 受教育程度 1.943 0.584 3.712 0.294 2.011 0.570 6.059 0.109 初中及以下 166 34(20.5) 119 34(28.6) 73 25(34.2) 967 27(2.8) 高中/中专/技校 198 30(15.2) 174 36(20.7) 91 23(25.3) 1 177 52(4.4) 大学专科 124 23(18.6) 145 31(21.4) 52 13(25.0) 1 273 55(4.3) 大学本科及以上 156 26(16.7) 239 48(20.1) 81 22(27.2) 2 551 118(4.6) 家庭人均年收入(万元) 5.278 0.071 6.626 0.036 3.022 0.221 3.584 0.167 < 1 196 46(23.5) 184 54(29.4) 99 25(25.2) 1 385 66(4.8) 1~<5 195 30(15.4) 174 42(24.1) 81 28(34.6) 1 585 56(3.5) ≥5 147 23(15.6) 203 37(18.2) 66 15(22.7) 1 620 76(4.7) 自报身体健康状况 16.983 0.001 18.656 < 0.001 1.340 0.720 很不或比较不健康 66 20(30.3) 69 21(30.4) 45 15(33.3) 一般 235 51(21.7) 257 72(28.0) 131 38(29.0) 比较健康 237 30(12.7) 258 47(18.2) 86 21(24.4) 很健康 106 12(11.3) 93 9(9.7) 35 9(25.7) -
[1] Kluge HHP, Wickramasinghe K, Rippin HL, et al. Prevention and control of non-communicable diseases in the COVID-19 response[J]. Lancet, 2020, 395(10238): 1678-1680. DOI: 10.1016/s0140-6736(20)31067-9. [2] Yan AF, Sun X, Zheng J, et al. Perceived risk, behavior changes and Health-related outcomes during COVID-19 pandemic: findings among adults with and without diabetes in China[J]. Diabetes Res Clin Pract, 2020, 167: 108350. DOI: 10.1016/j.diabres.2020.108350. [3] Chan EYY, Kim JH, Lo ESK, et al. What happened to people with non-communicable diseases during COVID-19: implications of H-EDRM policies[J]. Int J Environ Res Public Health, 2020, 17(15): 5588. DOI: 10.3390/ijerph17155588. [4] Wolf MS, Serper M, Opsasnick L, et al. Awareness, attitudes, and actions related to COVID-19 among adults with chronic conditions at the onset of the U.S. outbreak: a cross-sectional survey[J]. Ann Intern Med, 2020, 173(2): 100-109. DOI: 10.7326/M20-1239. [5] 潘雄飞, 王意, 叶依, 等. 流行病学研究中的样本代表性问题(二)[J]. 中华疾病控制杂志, 2019, 23(2): 125-128. DOI: 10.16462/j.cnki.zhjbkz.2019.02.001.Pan XF, Wang Y, Ye Y, et al. Representativeness issues in epidemiological studies(Ⅱ)[J]. Chin J Dis Control Prev, 2019, 23(2): 125-128. DOI: 10.16462/j.cnki.zhjbkz.2019.02.001. [6] 中商产业研究院. 2019年中国手机产销数据分析及2020年行业发展趋势预测[EB/OL]. (2020-01-09)[2021-03-11]. https://www.askci.com/news/chanye/20200109/1704371156221.shtml.Chinese Commercial Industry Research Institute. Analysis on cell phone production and marketing data of China in 2019 and forecast on industry development trend in 2020[EB/OL]. (2020-01-09)[2021-03-11]. https://www.askci.com/news/chanye/20200109/1704371156221.shtml. [7] 中国经济研究中心. 中国健康与养老调查家户问卷[EB/OL]. (2019-05-28)[2021-03-11]. http://charls.pku.edu.cn/Public/ashelf/public/uploads/document/public_documents/application/CHARLS2011-basline-questionare-PDF.pdf.China Center for Economic Research. China health and retirement longitudinal study-baseline questionnaire[EB/OL]. (2019-05-28)[2021-03-11]. http://charls.pku.edu.cn/Public/ashelf/public/uploads/document/public_documents/application/CHARLS2011-basline-questionare-PDF.pdf. [8] 搜狐网. 《中国居民营养与慢性病状况报告(2020年)》发布!这些数字与健康息息相关![EB/OL]. (2020-12-23)[2021-03-11]. https://www.sohu.com/a/440141342_655881.Sohu. Report on Chinese Residents' Nutrition and Chronic Diseases(2020) released! These numbers are closely related to our health![EB/OL]. (2020-12-23)[2021-03-11]. https://www.sohu.com/a/440141342_655881. [9] Hartnett KP, Kite-Powell A, DeVies J, et al. Impact of the COVID-19 pandemic on emergency department visits - United States, January 1, 2019-May 30, 2020[J]. MMWR Morb Mortal Week Rep, 2020, 69(23): 699-704. DOI: 10.15585/mmwr.mm6923e1. [10] World Health Organization. Delivering NCD services in a time of COVID-19 - stories from the field[EB/OL]. (2020-06-03)[2021-03-11]. https://www.euro.who.int/en/countries/italy/news/news/2020/6/delivering-ncd-services-in-a-time-of-COVID-19-stories-from-the-field. [11] Jia P, Zhang L, Yu W, et al. Impact of COVID-19 lockdown on activity patterns and weight status among youths in China: the COVID-19 Impact on Lifestyle Change Survey (COINLICS)[J]. Int J Obes (Lond), 2021, 45(3): 695-699. DOI: 10.1038/s41366-020-00710-4.